Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the pharmacokinetics of Ampicillin in newborns' umbilical cord blood and plasma after intrapartum administration for preventing early onset group B streptococcal infection (A prospective study).

La Clinica terapeutica·2025

Same author

Complications of electrosurgery: mechanisms and prevention strategies.

Facts, views & vision in ObGyn·2024

Same author

Obesity drives adipose-derived stem cells into a senescent and dysfunctional phenotype associated with P38MAPK/NF-KB axis.

Immunity & ageing : I & A·2023

Same author

Proficiency of some synthetic alginate derivatives for sequestration of Iodine-131 from radioactive liquid waste.

Environmental technology·2023

Same author

Multi-vendor multi-site quantitative MRI analysis of cartilage degeneration 10 Years after anterior cruciate ligament reconstruction: MOON-MRI protocol and preliminary results.

Osteoarthritis and cartilage·2022

Same author

Treatment of the syndrome of knee pain and meniscal tear in middle-aged and older persons: A narrative review.

Osteoarthritis and cartilage open·2022

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Expectant management of first-trimester miscarriage.

M M El-Sayed¹, S A Mohamed, M H Jones

¹Department of Obstetrics and Gynaecology, Darent Valley Hospital, Dartford, UK. mohsenmelsayed@hotmail.com

Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology

|October 14, 2009

Summary

Expectant management for first-trimester miscarriage is a safe and effective alternative to surgery. This approach offers women greater choice and control, with significant cost savings for healthcare systems.

Related Experiment Videos

Last Updated: Jun 19, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Area of Science:

Obstetrics and Gynecology
Reproductive Health
Clinical Evidence Review

Background:

Miscarriage is a common pregnancy complication, posing a significant burden on healthcare.
Surgical evacuation has been the standard treatment for first-trimester miscarriage.
Non-surgical management options are gaining popularity.

Purpose of the Study:

To review the evidence supporting expectant management for first-trimester miscarriage.
To evaluate the safety, efficacy, and patient experience of expectant management.
To compare expectant management with traditional surgical interventions.

Main Methods:

Systematic review of existing literature on expectant management of miscarriage.
Analysis of data regarding safety, effectiveness, patient tolerance, and cost-effectiveness.
Identification of key components for successful expectant management protocols.

Main Results:

Expectant management is demonstrated to be safe, effective, and well-tolerated by women.
This approach empowers women with enhanced choice and control over their healthcare decisions.
Expectant management offers considerable cost savings in comparison to surgical evacuation.

Conclusions:

Expectant management is a viable and beneficial option for first-trimester miscarriage.
Accurate diagnosis, comprehensive counseling, continuous support, and follow-up are crucial for successful implementation.
Further research is needed to refine methods for selecting appropriate cases for expectant management.